Last reviewed · How we verify
Bavarian Nordic smallpox vaccine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Bavarian Nordic smallpox vaccine (Bavarian Nordic smallpox vaccine) — McMaster University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bavarian Nordic smallpox vaccine TARGET | Bavarian Nordic smallpox vaccine | McMaster University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bavarian Nordic smallpox vaccine CI watch — RSS
- Bavarian Nordic smallpox vaccine CI watch — Atom
- Bavarian Nordic smallpox vaccine CI watch — JSON
- Bavarian Nordic smallpox vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Bavarian Nordic smallpox vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/bavarian-nordic-smallpox-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab